Showing results (701-710 of 905) with videos related to

Sort By:
Pageof 91
Archives of Public Health = Archives Belges De Sante Publique|May 14, 2020
Epidemiology of neonatal infections in hospitals of Nepal: evidence from a large- scale studyShyam Sundar Budhathoki, Avinash K Sunny, Pragya Gautam Paudel, et al.
Msphere|January 28, 2025
The circulating plasma microRNA signature in human visceral leishmaniasisRitirupa Roy, Cinthia L Hudachek, Shashi Bhushan Chauhan, et al.
Experimental Parasitology|August 27, 2013
Evaluation of a diospyrin derivative as antileishmanial agent and potential modulator of ornithine decarboxylase of Leishmania donovaniSudipta Hazra, Subhalakshmi Ghosh, Madhushree Das Sarma, et al.
Journal of Leukocyte Biology|January 12, 2017
Phenotypic and functional characteristics of HLA-DR<sup>+</sup> neutrophils in Brazilians with cutaneous leishmaniasisRichard E Davis, Smriti Sharma, Jacilara Conceição, et al.
Plos Neglected Tropical Diseases|May 26, 2012
Drug susceptibility in Leishmania isolates following miltefosine treatment in cases of visceral leishmaniasis and post kala-azar dermal leishmaniasisVasundhra Bhandari, Arpita Kulshrestha, Deepak Kumar Deep, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 13, 2012
Exon 45 skipping through U1-snRNA antisense molecules recovers the Dys-nNOS pathway and muscle differentiation in human DMD myoblastsValentina Cazzella, Julie Martone, Chiara Pinnarò, et al.
The Lancet. Infectious Diseases|April 2, 2011
Visceral leishmaniasis: elimination with existing interventionsGreg Matlashewski, Byron Arana, Axel Kroeger, et al.
Frontiers in Cellular and Infection Microbiology|December 16, 2021
A Novel Bioimpedance-Based Detection of Miltefosine Susceptibility Among Clinical <i>Leishmania donovani</i> Isolates of the Indian Subcontinent Exhibiting Resistance to Multiple DrugsSouradeepa Ghosh, Souvik Biswas, Sandip Mukherjee, et al.
Pageof 91